Literature DB >> 26780986

Single measurement of intact parathyroid hormone after thyroidectomy can predict transient and permanent hypoparathyroidism: a prospective study.

Montana Suwannasarn1, Wallaya Jongjaroenprasert1, Palapong Chayangsu2, Ronnarat Suvikapakornkul3, Chutintorn Sriphrapradang4.   

Abstract

OBJECTIVE: Immediate postoperative hypocalcemia is the most common complication of bilateral thyroidectomy. Although hypocalcemia is usually transient, it can be fatal. This study aimed to find a predictor of immediate postoperative hypocalcemia by using intact parathyroid hormone (PTH) level at 4 hours after thyroidectomy (iPTH4hr) compared with the decline in the percentage of intact PTH (%iPTH). We also followed the subjects for evaluation of permanent hypoparathyroidism.
METHODS: This was a prospective study of 65 patients (86.2% female, mean age: 43±15 years) who planned to undergo total or subtotal thyroidectomy. Preoperative and iPTH4hr were measured.
RESULTS: Thirty-nine patients (60%) were diagnosed with papillary thyroid carcinoma, while the rest were multinodular goiter (21.5%) and Graves' disease (7.7%). Significant immediate hypocalcemia was observed in 25 (38.5%) patients. Both iPTH4hr <12.5 pg/mL and %iPTH decline >72% could accurately predict significant immediate hypocalcemia. Sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) for iPTH4hr were 92%, 87.5%, 82.1%, and 94.6%, respectively. The %iPTH decline was equal in accuracy, with sensitivity, specificity, PPV, and NPV of 84%, 90%, 84%, and 90%, respectively. At 6 months after surgery, 19 patients (29.2%) displayed permanent hypoparathyroidism. The iPTH4hr <12.5 pg/mL and %iPTH decline >72% could also predict permanent hypoparathyroidism, with sensitivity, specificity, PPV, and NPV of 100%, 80.4%, 67.9%, and 100%, and 94.7%, 84.8%, 72%, and 97.5%, respectively.
CONCLUSIONS: Only a single measurement of iPTH4hr could be helpful in identifying patients at risk of significant immediate hypocalcemia in need prompt treatment, and subsequently facilitating early discharge of patients. Also, this parameter can precisely predict permanent hypoparathyroidism.
Copyright © 2015. Published by Elsevier Taiwan.

Entities:  

Keywords:  Hypocalcemia; Hypoparathyroidism; Parathyroid hormone; Thyroidectomy; Vitamin D

Mesh:

Substances:

Year:  2016        PMID: 26780986     DOI: 10.1016/j.asjsur.2015.11.005

Source DB:  PubMed          Journal:  Asian J Surg        ISSN: 1015-9584            Impact factor:   2.767


  9 in total

1.  Early corrected serum calcium value can predict definitive calcium serum level after total thyroidectomy in asymptomatic patients.

Authors:  A Houette; J Massoubre; B Pereira; M Puechmaille; A Dissard; L Gilain; N Saroul; T Mom
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-07-19       Impact factor: 2.503

2.  Role of perioperative parathormone hormone level assay after total thyroidectomy as a predictor of transient and permanent hypocalcemia: Prospective study.

Authors:  Mohamed S Essa; Khaled S Ahmad; Mohammed A Fadey; Mohamed O El-Shaer; Ahmed M F Salama; Mohamed E Zayed
Journal:  Ann Med Surg (Lond)       Date:  2021-08-10

3.  How Long Does It Take to Regain Normocalcaemia in the Event of Postsurgical Hypoparathyroidism? A Detailed Time Course Analysis.

Authors:  Laura Guglielmetti; Sina Schmidt; Mirjam Busch; Joachim Wagner; Ali Naddaf; Barbara Leitner; Simone Harsch; Andreas Zielke; Constantin Smaxwil
Journal:  J Clin Med       Date:  2022-06-03       Impact factor: 4.964

4.  The predictive factors for postoperative hypoparathyroidism and its severity on the first postoperative day after papillary thyroid carcinoma surgery.

Authors:  Renhong Huang; Qiang Wang; Wei Zhang; Siluo Zha; Daozhen Jiang; Xinyun Xu; Xiangmin Zheng; Ming Qiu; Chengxiang Shan
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-07-20       Impact factor: 2.503

5.  Role of postoperative intact serum PTH as an early predictor of severe post-thyroidectomy hypocalcemia: a prospective study.

Authors:  S Mattoo; A Agarwal; S Mayilvaganan; P Mishra; G Agarwal; A Mishra; G Chand; S K Gupta; S K Mishra
Journal:  J Endocrinol Invest       Date:  2021-01-27       Impact factor: 4.256

6.  Assessment of the Early and Late Complication after Thyroidectomy.

Authors:  Esmaeil Chahardahmasumi; Rezvan Salehidoost; Massoud Amini; Ashraf Aminorroaya; Hassan Rezvanian; Ali Kachooei; Bijan Iraj; Masoud Nazem; Mohsen Kolahdoozan
Journal:  Adv Biomed Res       Date:  2019-02-27

7.  European Expert Consensus on Practical Management of Specific Aspects of Parathyroid Disorders in Adults and in Pregnancy: Recommendations of the ESE Educational Program of Parathyroid Disorders.

Authors:  Jens Bollerslev; Lars Rejnmark; Alexandra Zahn; Ansgar Heck; N M Appelman-Dijkstra; Luis Cardoso; Fadil M Hannan; Filomena Cetani; Tanja Sikjær; Anna Maria Formenti; Sigridur Björnsdottir; Camilla Schalin-Jantti; Zhanna Belaya; Fraser Wilson Gibb; Bruno Lapauw; Karin Amrein; Corinna Wicke; Corinna Grasemann; Michael Krebs; Eeva M Ryhänen; Ozer Makay; Salvatore Minisola; Sebastien Gaujoux; Jean-Philippe Bertocchio; Zaki K Hassan-Smith; Agnès Linglart; Elizabeth M Winter; Martina Kollmann; Hans-Georg Zmierczak; Elena Tsourdi; Stefan Pilz; Heide Siggelkow; Neil J Gittoes; Claudio Marcocci; Peter Kamenicky
Journal:  Eur J Endocrinol       Date:  2022-01-13       Impact factor: 6.664

8.  Definition and diagnosis of postsurgical hypoparathyroidism after thyroid surgery: meta-analysis.

Authors:  Kathrin Nagel; Anne Hendricks; Christina Lenschow; Michael Meir; Stefanie Hahner; Martin Fassnacht; Armin Wiegering; Christoph-Thomas Germer; Nicolas Schlegel
Journal:  BJS Open       Date:  2022-09-02

9.  The Reality of Hypoparathyroidism After Thyroidectomy: Which Risk Factors are Effective? Single-Center Study.

Authors:  Ismail Ethem Akgun; Mehmet Taner Unlu; Nurcihan Aygun; Mehmet Kostek; Aydin Eray Tufan; Ceylan Yanar; Ali Yuksel; Elif Baran; Yasin Cakir; Mehmet Uludag
Journal:  Sisli Etfal Hastan Tip Bul       Date:  2022-06-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.